(Q34352811)

English

Migraine and haemostasis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

Migraine and haemostasis (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

Marie-Germaine Bousser

3

0 references

author name string

I Crassard

1

1 reference

Europe PubMed Central

1 August 2017

J Conard

2

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

21

1 reference

Europe PubMed Central

1 August 2017

630-636

1 reference

Europe PubMed Central

1 August 2017

6

1 reference

Europe PubMed Central

1 August 2017

Migrainous stroke

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Case-control study of migraine and risk of ischaemic stroke in young women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Association between migraine and stroke in a large-scale epidemiological study of the United States.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Migraine and the mitral valve prolapse syndrome.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Platelets as a model for neurones?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Migraine: a platelet disorder

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Platelet aggregability in migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

ATP hyposecretion from platelet dense bodies--evidence for the purinergic hypothesis and a marker of migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Low-dose aspirin for migraine prophylaxis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Effects of methysergide on platelets incubated with reserpine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Migrainous phenomena in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Cerebral infarction associated with lupus anticoagulants--preliminary report

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Migraine and anti-phospholipid antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2001.00205.X

21 January 2018

Identifiers

10.1046/J.1468-2982.2001.00205.X

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34352811&oldid=2039661210"